Robin Respaut
@RobinRespaut
Followers
3K
Following
6K
Media
183
Statuses
2K
Healthcare, financial, data journalist for Reuters. [email protected]
San Francisco
Joined April 2009
Our latest story examines new data showing the rise of adolescents taking Wegovy, GLP1s, for weight-loss. With @chadterhune
reuters.com
A small but rapidly growing number of U.S. adolescents began treatment with Novo Nordisk's NOVOb.CO weight-loss drug Wegovy last year, a powerful new tool to address record rates of pediatric...
0
1
6
Exclusive: US families begin to embrace weight-loss drugs for their children, data show. My latest w/ @RobinRespaut #obesity #wegovy #pediatrics
reuters.com
A small but rapidly growing number of U.S. adolescents began treatment with Novo Nordisk's NOVOb.CO weight-loss drug Wegovy last year, a powerful new tool to address record rates of pediatric...
0
3
3
As sales soar for Wegovy and Ozempic, there’s growing debate on how widely these powerful and expensive weight-loss medications should be prescribed and for how long https://t.co/Q3ZNMuhIJw by @chadterhune @RobinRespaut via @specialreports
8
10
17
Novo Nordisk, maker of Wegovy and Ozempic, has spent millions of dollars on doctors and obesity experts who exert influence over how weight-loss drugs are dispensed and covered by insurance https://t.co/JNyQFaut1g by @chadterhune @RobinRespaut via @specialreports
1
13
21
Some top obesity experts are promoting weight-loss drugs for tens of millions of Americans. Some of those same doctors also took large amounts of money from Novo Nordisk, the maker of Wegovy and Ozempic, @Reuters found https://t.co/nl5D3BLlJD by @chadterhune @RobinRespaut
4
21
26
How Novo Nordisk forged financial ties with leading obesity doctors with broad influence over how weight-loss drugs like Wegovy are used. @Reuters investigates https://t.co/rJk6RkcTMx by @chadterhune @RobinRespaut via @specialreports
2
13
16
My latest story with colleague @RobinRespaut. We dug into the FDA's adverse events database, filed public records requests and interviewed numerous doctors and patients about this potential safety issue #obesity #patientsafety
reuters.com
The US Food and Drug Administration received more than 250 reports of patients experiencing suicidal thoughts or behaviors while taking Ozempic or similar medicines since 2010, Reuters found in an...
2
3
1
Our latest story describes the experiences of patients who took the new, popular weight-loss drugs and experienced suicidal thoughts. https://t.co/eIQrk8SHDl with @chadterhune
reuters.com
The US Food and Drug Administration received more than 250 reports of patients experiencing suicidal thoughts or behaviors while taking Ozempic or similar medicines since 2010, Reuters found in an...
2
4
2
Are you an early career Indian photographer? @Reuters has launched the Danish Siddiqui Photojournalism Internship in memory of our late colleague who continues to inspire us all. This year-long, paid internship, will be based in Delhi. Join our team: https://t.co/jSxgXYjgRl
14
388
567
Our latest: Merck’s best-selling asthma and allergy medicine, Singulair, has been linked for years to suicides and psychiatric problems, often in children. https://t.co/oDkZYjgeyN w/@FedcourtJunkie @kristinacooke @mike_d_spector and Ben Lesser
reuters.com
Merck’s asthma drug, Singulair, has been linked for years to suicides. But lawsuits over it are stymied by one of Corporate America’s go-to legal defenses.
0
3
4
Nicholas England, a healthy 22-year-old from Virginia, shot himself in the head in 2017 shortly after starting to take an allergy medicine. His parents were blocked from suing drug companies by Supreme Court precedents https://t.co/T7ZYn8n9zy
5
42
76
Congratulations to @RobinRespaut, @chadterhune, @michelleconlin and @jriggers of @Reuters for winning @NIHCM's 2023 General Circulation Journalism Award for their excellent series, "Youth in Transition." Well deserved!
Announcing the winners for the 2023 #NIHCM Awards in Journalism and Research! https://t.co/LmEFdwE1Qu
#NIHCMAwardsJournalism #NIHCMAwardsResearch
@KFFHealthNews @NPR @CBSNews @Reuters @NewsfromScience @aftershockdoc @OnyxCollective @abcnews @hulu @AEAjournals
1
8
16
Announcing the winners for the 2023 #NIHCM Awards in Journalism and Research! https://t.co/LmEFdwE1Qu
#NIHCMAwardsJournalism #NIHCMAwardsResearch
@KFFHealthNews @NPR @CBSNews @Reuters @NewsfromScience @aftershockdoc @OnyxCollective @abcnews @hulu @AEAjournals
0
15
13
This was farmland in the southern San Joaquin Valley (Kings County, south of Corcoran). #flooding It’s now more of an ocean
213
816
3K
As African kids died, doctors fought for ban on toxic Indian syrup. A haunting special report by @Reuters
reuters.com
A known toxin lurked in cough syrup taken by children in Gambia. Doctors faced a fight to prove it. India, where the syrups were made, denies a connection.
0
1
1
INSANE conditions on Mt Washington, NH. 120mph+ winds and -95°F wind chill. It is above the tropopause, meaning that these are stratospheric winds. Footage from the summit live stream 2:30-2:40pm. #nhwx
2K
11K
64K
My baby's cancer may have returned and my insurance, @Cigna, is refusing to help cover a PET scan so we can find out if it has, and if needed, continue our work to save his life. No qualms about putting my child's life on the line for their bottom line. He is not even 2 years old
786
7K
37K
Our latest story about why detransitioners are crucial to the science of gender care, with @chadterhune @michelleconlin
reuters.com
Understanding why people quit treatment is key to improving it, especially for minors seeking to transition, experts say. Researchers rarely touch the subject.
7
21
62
Demand for care among England’s trans teens is growing. So are obstacles to treatment https://t.co/E6s7Oprynq with @chadterhune @RobinRespaut
reuters.com
A care overhaul for transgender minors is exacerbating bottlenecks in England, adding to years-long treatment delays.
1
5
7
Adolescents assigned female at birth account for a significant majority of minors receiving gender-affirming care, including top surgery, fueling debate about the influence of peer groups and social media https://t.co/AJfr1qxKfw via @specialreports
26
17
39